Join the Schizoaffective Disorder group to help and get support from people like you.
Schizoaffective Disorder News (Page 2)
Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders
WEDNESDAY, Oct. 23, 2024 – Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in Heart. Jasmin Mujkanovic, from...
High Rate of Comorbid Mental Health Disorders Seen in Schizophrenia
TUESDAY, Oct. 8, 2024 – Adults with schizophrenia spectrum disorders have high rates of comorbid mental health and substance use disorders, according to a study published online Sept. 23 in...
Most People With Schizophrenia Aren't Getting Treated
WEDNESDAY, Sept. 25, 2024 – Only 1 in every 4 U.S. adults struggling with schizophrenia receive "minimally adequate treatment," new data shows. Many of these patients also struggle with other mental...
Childhood BMI Linked to Increased Risk for Schizophrenia
MONDAY, Sept. 16, 2024 – Childhood body mass index (BMI) has a direct and enduring effect on the risk for schizophrenia later in life, according to a study published online Sept. 13 in Science...
FDA Approves Erzofri (paliperidone palmitate) for the Treatment of Schizophrenia and Schizoaffective Disorder
PRINCETON, N.J., July 28, 2024 – Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that ...
FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure
ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A,...
FDA Approves sNDA for Invega Sustenna (paliperidone palmitate) for Schizoaffective Disorder
TITUSVILLE, N.J., Nov. 13, 2014 /PRNewswire/ – Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs)...
Further information
Related condition support groups
Related drug support groups
Prozac, Seroquel, Abilify, fluoxetine, lithium, lamotrigine, quetiapine, olanzapine, risperidone, view more... Risperdal, aripiprazole, Seroquel XR, Geodon, Invega, Tegretol, lurasidone, Invega Sustenna